Eris Lifesciences

Important Information/ Views

Eris Lifesciences enters into insulin segment
December 4, 2021
Eris has formed a JV with MJ Biopharm for this purpose. Key points to note – Eris will hold 70% of the JV and MJ 30%. MJ is also getting ... Read more

Do you have something important to share about the Company?

Submit Now
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Disclaimer: Nothing on this website should be considered as an advice to invest. The sole purpose of everything written here is information/ knowledge sharing. Reader is requested to do his independent research and/ or take professional services from SEBI registered advisors for any investment related decision.

Forgot Password
Please enter your email address or username below.
*
Username OR Email Address
Username can not be left blank.
Please enter valid data.
Submit
 
Please Login
*
Username or email
Username can not be left blank.
Please enter valid data.
*
Password
Password can not be left blank.
Please enter valid data.
Please enter at least 1 characters.
LOGIN
 
 
0
Would love your thoughts, please comment.x